Evaluation of the use of Hypertonic Saline 3% Nebulizer versus Intravenous Hypertonic Saline 3% to Attenuate the Manifestations of Acute Respiratory Distress Syndrome

Fig. (2) Group A (saline N): Standard pharmacotherapy +normal saline 0.9% (5ml) nebulizer /8hr. Group B(H saline N): Standard pharmacotherapy + hypertonic saline 3% (5ml) nebulizer /8hr. Group C(saline IV):Standard pharmacotherapy + normal saline 0.9% (500ml) intravenous /24hr. Group B(H saline IV): Standard pharmacotherapy + hypertonic saline 3% (500ml) intravenous /24hr. Bar chart between groups according to the need for mechanical ventilation.